“Anti-inflammatory interleukins (IL-4 and IL-10) and their relationship with the severity of COVID-19: A systematic review”, RSD, vol. 14, no. 3, p. e4214348459, Mar. 2025, doi: 10.33448/rsd-v14i3.48459.